BackU.S. Stem Cell Overview

U.S. Stem Cell Accounts Payable

See how USRM's accounts payable trends over time vs similar companies.

Get informed when a big investor buys or sells

+ Follow
Accounts Payable
N/A

Peer trimmed avg / median

Loading

U.S. Stem Cell Accounts Payable History

Loading

U.S. Stem Cell vs. peers: Accounts Payable Comparison

Loading

U.S. Stem Cell Accounts Payable Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

U.S. Stem Cell (USRM) FAQ

Stockcircle tracks accounts payable for U.S. Stem Cell (USRM), including historical charts and peer comparisons when data is available. Check back as new filings are published, or open the stock overview for a broader fundamental snapshot.

This Accounts Payable page is built for U.S. Stem Cell's historical accounts payable trend and peer context. When enough reporting periods are on file, the charts below visualize how the metric has moved over time.

Use accounts payable as one input alongside growth, profitability, valuation, and ownership activity. Stockcircle links related metric pages and the main USRM overview so you can move from this figure to the surrounding analysis quickly.